Compare SCNX & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNX | TGE |
|---|---|---|
| Founded | 2010 | 2023 |
| Country | United States | France |
| Employees | N/A | 166 |
| Industry | Other Pharmaceuticals | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 17.6M |
| IPO Year | 2019 | N/A |
| Metric | SCNX | TGE |
|---|---|---|
| Price | $3.05 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.7K | ★ 833.4K |
| Earning Date | 11-24-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,831,778.00 | N/A |
| Revenue This Year | $743.36 | N/A |
| Revenue Next Year | $325.03 | N/A |
| P/E Ratio | ★ N/A | $2.99 |
| Revenue Growth | ★ 30.72 | N/A |
| 52 Week Low | $2.64 | $0.22 |
| 52 Week High | $106.25 | $1.69 |
| Indicator | SCNX | TGE |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 22.55 |
| Support Level | $2.64 | N/A |
| Resistance Level | $3.68 | $0.99 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.24 | -0.03 |
| Stochastic Oscillator | 43.27 | 7.34 |
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.